Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$0.75 - $1.29 $5,763 - $9,912
-7,684 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$0.33 - $1.62 $145 - $716
-442 Reduced 5.44%
7,684 $7,000
Q4 2019

Feb 05, 2020

SELL
$1.23 - $2.67 $84 - $184
-69 Reduced 0.84%
8,126 $13,000
Q3 2019

Nov 08, 2019

SELL
$1.25 - $5.0 $72 - $290
-58 Reduced 0.7%
8,195 $18,000
Q2 2019

Aug 13, 2019

BUY
$1.65 - $6.72 $815 - $3,319
494 Added 6.37%
8,253 $17,000
Q1 2019

May 06, 2019

BUY
$4.84 - $9.07 $18,329 - $34,348
3,787 Added 95.34%
7,759 $54,000
Q4 2018

Feb 13, 2019

SELL
$4.21 - $14.28 $134 - $456
-32 Reduced 0.8%
3,972 $25,000
Q3 2018

Nov 09, 2018

BUY
$13.02 - $17.54 $52,132 - $70,230
4,004 New
4,004 $56,000

Others Institutions Holding ECOR

About electroCore, Inc.


  • Ticker ECOR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 71,176,896
  • Market Cap $427M
  • Description
  • electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....
More about ECOR
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.